The two-year impact of first generation protease inhibitor based antiretroviral therapy (PI-ART) on health-related quality of life

Health and Quality of Life Outcomes

Volumn 3, Issue , 2005, Pages

  Eriksson, Lars E ^a,b,c   Bratt, Göran A ^b   Nordström, Gun ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DETERIORATION; EMOTION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PHYSICAL CAPACITY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; SIDE EFFECT; DRUG COMBINATION; EPIDEMIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; SICKNESS IMPACT PROFILE; SWEDEN; TIME; TREATMENT OUTCOME;

ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; SAMPLING STUDIES; SICKNESS IMPACT PROFILE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 27344447592     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-3-32     Document Type: Article

References (46)

1. British HIV Association Writing Committee: British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med 2003, 4(Suppl 1):1-41.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860.
3. Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD: AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 2000, 356:291-296.
4. Safrin S, Grunfeld C: Fat distribution and metabolic changes in patients with HIV infection. AIDS 1999, 13:2493-2505.
5. Carr A, Cooper DA: Adverse effects of antiretroviral therapy. Lancet 2000, 356:1423-1430.
6. Ragsdale D, Morrow JR: Quality of life as a function of HIV classification. Nurs Res 1990, 39:355-359.
7. Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD: A health status questionnaire using 30 items from the Medical Outcomes Study. Med Care 1991, 29:786-798.
8. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C: Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study Instrument. Ann Intern Med 1992, 116:129-137.
9. Holzemer WL, Wilson HS: Quality of life and the spectrum of HIV infection. Annu Rev Nurs Res 1995, 13:3-29.
10. Wu AW, Rubin HR: Approaches to health status assessment in HIV disease overview of the conference. Psychol Health 1994, 9:1-18.
11. Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS: Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res 2000, 9:977-985.
12. Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD: Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med 2001, 134:854-860.
13. Murri R, Fantoni M, Borgo CD, Visona R, Barracco A, Zambelli A, Testa L, Orchi N, Tozzi V, Bosco O, Wu AW: Determinants of health-related quality of life in HIV-infected patients. AIDS Care 2003, 15:581-590.
14. Ichikawa M, Natpratan C: Quality of life among people living with HIV/AIDS in northern Thailand: MOS-HIV Health Survey. Qual Life Res 2004, 13:601-610.
15. Kemmler G, Schmied B, Shetty-Lee A, Zangerle R, Hinterhuber H, Schüssler G, Mumelter B: Quality of life of HIV-infected patients: psychometric properties and validation of the German version of the MQOL-HIV. Qual Life Res 2003, 12:1037-1050.
16. de Boer JB, van Dam FSAM, Sprangers MAG: Health-related quality-of-life evaluation in HIV-infected patients. A Review of the literature. Pharmacoeconomics 1995, 8:291-304.
17. Nieuwkerk PT, Gisolf EH, Reijers MHE, Lange JMA, Danner SA, Sprangers MAG: Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS 2001, 15:1985-1991.
18. Burgoyne RW, Rourke SB, Behrens DM, Salit IE: Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile. AIDS Behav 2004, 8:151-163.
19. Burgoyne R, Renwick R: Social support and quality of life over time among adults living with HIV in the HAART era. Soc Sci Med 2004, 58:1353-1366.
20. Brorsson B, Ifver J, Hays RD: The Swedish Health-Related Quality of Life Survey (SWED-QUAL). Qual Life Res 1993, 2:33-45.
21. Stewart AL, Hays RD, Ware JE: The MOS Short-form General Health Survey: Reliability and validity in a patient population. Med Care 1988, 26:724-735.
22. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M: The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 1989, 262:925-930.
23. Stewart AL, Sherbourne CD, Hays RD, Wells KB, Nelson EC, Kamberg CJ, Rogers WH, Berry SH, Ware JE: Summary and discussion of MOS measures. In Measuring Functioning and Well-Being The Medical Outcomes Study Approach Edited by: Stewart AL, Ware JE. Duram, NC: Duke University Press; 1992:345-371.
24. Ware JE, Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
25. Eriksson LE, Nordström G, Berglund T, Sandström E: The health-related quality of life in a Swedish sample of HIV-infected persons. J Adv Nurs 2000, 32:1213-1223.
26. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
27. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. Centers for Disease Control and Prevention. MMWR Recom Rep 1994, 43:1-21.
28. Hejdeman B, Lenkei R, Leandersson A-C, Hultström AL, Wahren B, Sandström E, Bratt G: Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection. AIDS Res Hum Retroviruses 2001, 17:277-286.
29. Shott S: Statistics for health professionals Philadelphia: W.B. Saunders Company; 1990.
30. Fayers PM, Machin D: Quality of life: assessment, analysis, and interpretation West Sussex, England: John Wiley & Sons Ltd; 2000.
31. Cohen J, Cohen P: Applied multiple regression/correlation analysis for the behavioral sciences Second edition. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc; 1983.
32. Wu AW, Rubin HR, Mathews WC, Brysk LM, Bozzette SA, Hardy WD, Atkinson JH, Grant I, Spector SA, McCutchan JA, Richman DD: Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. J Acquir Immune Defic Syndr 1993, 6:452-458.
33. Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA: Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Med Care 2000, 38:404-410.
34. Goujard C, Bernard N, Sohier N, Peyramond D, Lançon F, Chwalow J, Arnould B, Delfraissy J-F: Impact of a patient education program on adherence to HIV medication. J Acquir Immune Defic Syndr 2003, 34:191-194.
35. Lubeck DP, Fries JF: Changes in quality of life among persons with HIV infection. Qual Life Res 1992, 1:359-366.
36. Low-Beer S, Chan K, Yip B, Wood W, Montaner JSG, O'Shaughnessy MV, Hogg RS: Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr 2000, 23:295-301.
37. Carrieri P, Spire B, Duran S, Katlama C, Peyramond D, Francois C, Chene G, Lang JM, Moatti JP, Leport C: Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003, 32:38-47.
38. Rabkin J, Ferrando S, Lin S, Sewell M, McElhiney M: Psychological effect of HAART: a 2-year study. Psychosom Med 2000, 62:413-422.
39. Blanch J, Rousaud A, Martinez E, Lazzari ED, Milinkovic A, Peri J-M, Blanco J-L, Jaen J, Navarro V, Massana G, Gatell J-M: Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1. Clin Infect Dis 2004, 38:1464-1470.
40. Hudson A, Kirksey K, Holzemer W: The influence of symptoms on quality of life among HIV-infected women. West J Nurs Res 2004, 26:9-23.
41. Préau M, Leport C, Salmon-Ceron D, Carrieri P, Portier H, Chene G, Spire B, Choutet P, Raffi F, Morin M, APROCO Study Group: Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment. AIDS Care 2004, 16:649-661.
42. Tramarin A, Parise N, Campostrini S, Yin DD, Postma MJ, Lyu R, Grisetti R, Capetti A, Cattelan AM, Di Toro MT, Mastroianni A, Pignattari E, Mondardini V, Calleri G, Raise E, Starace F, Palladio Study Group: Association between diarrhea and quality of life in HIV-infected patients receiving highly active antiretroviral therapy. Qual Life Res 2004, 13:243-250.
43. Erlen JA, Mellors MP: Adherence to combination therapy in persons living With HIV: balancing the hardships and the blessings. J Assoc Nurses AIDS Care 1999, 10:75-84.
44. Holzemer WL, Corless IB, Nokes KM, Turner JG, Brown MA, Powell-Cope GM, Inouye J, Henry SB, Nicholas PK, Portillo CJ: Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999, 13:185-197.
45. Stone VE, Jordan J, Tolson J, Miller R, Pilon T: Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr 2004, 36:808-816.
46. Fumaz CR, Tuldrà A, Ferrer MJ, Paredes R, Bonjoch A, Jou J, Negredo E, Romeu J, Sirera G, Tural C, Clotet B. Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens. J Acquir Immune Defic Syndr 2002, 29:244-253.